TY - JOUR
T1 - Second-Line Conservative Device-Assisted Intravesical Treatment in Selected Patients With Recurrent High-Risk Non–Muscle-Invasive Bladder Cancer
AU - Di Gianfrancesco, Luca
AU - Ragonese, Mauro
AU - Palermo, Giuseppe
AU - Sacco, Emilio
AU - Bassi, Pierfrancesco
AU - Racioppi, Marco
PY - 2020
Y1 - 2020
N2 - In case of recurrent high risk non–muscle-invasive bladder cancer, radical cystectomy is recommended because of its oncologic superiority over further conservative treatments. Major surgery greatly affects quality of life, and patients may prefer to preserve the native bladder. Device-assisted therapy, which resulted in satisfactory oncologic results, especially in selected patients, shows promise and is worth further careful evaluation.
AB - In case of recurrent high risk non–muscle-invasive bladder cancer, radical cystectomy is recommended because of its oncologic superiority over further conservative treatments. Major surgery greatly affects quality of life, and patients may prefer to preserve the native bladder. Device-assisted therapy, which resulted in satisfactory oncologic results, especially in selected patients, shows promise and is worth further careful evaluation.
KW - Conservative treatment
KW - Decision making process
KW - Device-assisted therapy
KW - Outcomes
KW - Radical cystectomy
KW - Conservative treatment
KW - Decision making process
KW - Device-assisted therapy
KW - Outcomes
KW - Radical cystectomy
UR - http://hdl.handle.net/10807/169426
U2 - 10.1016/j.clgc.2020.11.002
DO - 10.1016/j.clgc.2020.11.002
M3 - Article
SN - 1558-7673
SP - N/A-N/A
JO - Clinical Genitourinary Cancer
JF - Clinical Genitourinary Cancer
ER -
